Here are four events to look out for in May and June. Motif Bio, Pressure Technologies, TechFinancials and Mereo Biopharma are all set to make announcements that could have a significant effect on each individual share price.
Motif Bio (LON: MTFB)
Motif Bio had high hopes for its Iclaprim treatment for acute bacterial skin and skin structure infections. However, these hopes were severely dented. The result of a meeting with the FDA will be significant to getting back on track and a recovery in the share price.
The complete response letter from the US FDA was received in February...
